+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Cell Analysis Market By Product, By Techniques, By End User, By Application: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 270 Pages
  • July 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671114
The global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031.

Single-cell analysis (SCA) is essential in order to show population heterogeneity, identify minority sub-populations of interest, and learn about the particular traits of individual cells. Microfluidic systems are useful for manipulating single cells since they operate at a scale similar to cell diameter. A microfluidic array capable of quickly and deterministically trapping individual cells in densely packed microwells. This trapping array can be linked with multiple microfluidic sample processing units with variable flow rates for various single-cell studies because the single-cell trapping efficiency is dictated by the channel design rather than the flow rate. SCA is also commonly used in plant biology, prenatal diagnostics, microbiology, immunology, and neuroscience.

The major factors that drive the growth of the global single cell analysis market include technological advancement in single cell analysis and increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, growing focus on personalized medicines and surge in prevalence of cancer further propel the market growth. However, high cost of single cell analysis products is expected to restrain the growth of the single cell analysis market during the forecast period. Conversely, high growth potential of single cell sequencing is anticipated to provide lucrative opportunities to the market players.

The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include the Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Consumables
  • Instruments

By Techniques

  • Flow Cytometry
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Mass Spectrometry
  • Others

By End User

  • Academic and Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Others

By Application

  • Oncology
  • Immunology
  • Neurology
  • Stem cell
  • Non-Invasive Prenatal Diagnosis
  • In-Vitro Fertilization (IVF)
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Danaher Corporation(Cytiva Life Sciences)
  • Illumina, Inc.
  • BERKLEY LIGHTS INC
  • BGI GENOMICS CO. LTD
  • DIASORIN GROUP (LUMINEX CORPORATION)
  • DOLOMITE BIO
  • MERCK KGAA
  • OXFORD NANAOPORE TECHNOLOGIES
  • QIAGEN N.V
  • Sartorius AG
  • STANDARD BIOTOOLS (Fluidigm Corporation)
  • TAKARA HOLDINGS INC
  • THERMO FISHER SCIENTIFIC, INC.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Consumables
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Instruments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Oncology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Immunology
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Neurology
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Stem cell
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Non-Invasive Prenatal Diagnosis
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 In-Vitro Fertilization (IVF)
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Others
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES
6.1 Overview
6.1.1 Market size and forecast
6.2 Flow Cytometry
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Next Generation Sequencing (NGS)
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Polymerase Chain Reaction (PCR)
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Mass Spectrometry
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Academic and Research Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Biotechnology and Pharmaceutical Companies
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Hospitals and Diagnostic Laboratories
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.3 North America Market size and forecast, by Application
8.2.4 North America Market size and forecast, by Techniques
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Application
8.2.6.1.3 Market size and forecast, by Techniques
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Application
8.2.6.2.3 Market size and forecast, by Techniques
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Application
8.2.6.3.3 Market size and forecast, by Techniques
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.3 Europe Market size and forecast, by Application
8.3.4 Europe Market size and forecast, by Techniques
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Application
8.3.6.1.3 Market size and forecast, by Techniques
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Application
8.3.6.2.3 Market size and forecast, by Techniques
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Application
8.3.6.3.3 Market size and forecast, by Techniques
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Application
8.3.6.4.3 Market size and forecast, by Techniques
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Application
8.3.6.5.3 Market size and forecast, by Techniques
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Application
8.3.6.6.3 Market size and forecast, by Techniques
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.3 Asia-Pacific Market size and forecast, by Application
8.4.4 Asia-Pacific Market size and forecast, by Techniques
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Application
8.4.6.1.3 Market size and forecast, by Techniques
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Application
8.4.6.2.3 Market size and forecast, by Techniques
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Application
8.4.6.3.3 Market size and forecast, by Techniques
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Application
8.4.6.4.3 Market size and forecast, by Techniques
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Application
8.4.6.5.3 Market size and forecast, by Techniques
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Application
8.4.6.6.3 Market size and forecast, by Techniques
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.3 LAMEA Market size and forecast, by Application
8.5.4 LAMEA Market size and forecast, by Techniques
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Application
8.5.6.1.3 Market size and forecast, by Techniques
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Application
8.5.6.2.3 Market size and forecast, by Techniques
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Application
8.5.6.3.3 Market size and forecast, by Techniques
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Application
8.5.6.4.3 Market size and forecast, by Techniques
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 10x Genomics
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Agilent Technologies, Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Becton, Dickinson and Company
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Bio-Rad Laboratories
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Danaher Corporation(Cytiva Life Sciences)
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Illumina, Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 BERKLEY LIGHTS INC
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 BGI GENOMICS CO. LTD
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 DIASORIN GROUP (LUMINEX CORPORATION)
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 DOLOMITE BIO
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 MERCK KGAA
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 OXFORD NANAOPORE TECHNOLOGIES
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 QIAGEN N.V
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Sartorius AG
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 STANDARD BIOTOOLS (Fluidigm Corporation)
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 TAKARA HOLDINGS INC
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 THERMO FISHER SCIENTIFIC, INC.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
List of Tables
Table 1. Global Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 2. Single Cell Analysis Market Size, for Consumables, by Region, 2021-2031 ($Million)
Table 3. Single Cell Analysis Market for Consumables, by Country, 2021-2031 ($Million)
Table 4. Single Cell Analysis Market Size, for Instruments, by Region, 2021-2031 ($Million)
Table 5. Single Cell Analysis Market for Instruments, by Country, 2021-2031 ($Million)
Table 6. Global Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 7. Single Cell Analysis Market Size, for Oncology, by Region, 2021-2031 ($Million)
Table 8. Single Cell Analysis Market for Oncology, by Country, 2021-2031 ($Million)
Table 9. Single Cell Analysis Market Size, for Immunology, by Region, 2021-2031 ($Million)
Table 10. Single Cell Analysis Market for Immunology, by Country, 2021-2031 ($Million)
Table 11. Single Cell Analysis Market Size, for Neurology, by Region, 2021-2031 ($Million)
Table 12. Single Cell Analysis Market for Neurology, by Country, 2021-2031 ($Million)
Table 13. Single Cell Analysis Market Size, for Stem Cell, by Region, 2021-2031 ($Million)
Table 14. Single Cell Analysis Market for Stem Cell, by Country, 2021-2031 ($Million)
Table 15. Single Cell Analysis Market Size, for Non-Invasive Prenatal Diagnosis, by Region, 2021-2031 ($Million)
Table 16. Single Cell Analysis Market for Non-Invasive Prenatal Diagnosis, by Country, 2021-2031 ($Million)
Table 17. Single Cell Analysis Market Size, for In-Vitro Fertilization (Ivf), by Region, 2021-2031 ($Million)
Table 18. Single Cell Analysis Market for In-Vitro Fertilization (Ivf), by Country, 2021-2031 ($Million)
Table 19. Single Cell Analysis Market Size, for Others, by Region, 2021-2031 ($Million)
Table 20. Single Cell Analysis Market for Others, by Country, 2021-2031 ($Million)
Table 21. Global Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 22. Single Cell Analysis Market Size, for Flow Cytometry, by Region, 2021-2031 ($Million)
Table 23. Single Cell Analysis Market for Flow Cytometry, by Country, 2021-2031 ($Million)
Table 24. Single Cell Analysis Market Size, for Next Generation Sequencing (Ngs), by Region, 2021-2031 ($Million)
Table 25. Single Cell Analysis Market for Next Generation Sequencing (Ngs), by Country, 2021-2031 ($Million)
Table 26. Single Cell Analysis Market Size, for Polymerase Chain Reaction (Pcr), by Region, 2021-2031 ($Million)
Table 27. Single Cell Analysis Market for Polymerase Chain Reaction (Pcr), by Country, 2021-2031 ($Million)
Table 28. Single Cell Analysis Market Size, for Mass Spectrometry, by Region, 2021-2031 ($Million)
Table 29. Single Cell Analysis Market for Mass Spectrometry, by Country, 2021-2031 ($Million)
Table 30. Single Cell Analysis Market Size, for Others, by Region, 2021-2031 ($Million)
Table 31. Single Cell Analysis Market for Others, by Country, 2021-2031 ($Million)
Table 32. Global Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 33. Single Cell Analysis Market Size, for Academic and Research Laboratories, by Region, 2021-2031 ($Million)
Table 34. Single Cell Analysis Market for Academic and Research Laboratories, by Country, 2021-2031 ($Million)
Table 35. Single Cell Analysis Market Size, for Biotechnology and Pharmaceutical Companies, by Region, 2021-2031 ($Million)
Table 36. Single Cell Analysis Market for Biotechnology and Pharmaceutical Companies, by Country, 2021-2031 ($Million)
Table 37. Single Cell Analysis Market Size, for Hospitals and Diagnostic Laboratories, by Region, 2021-2031 ($Million)
Table 38. Single Cell Analysis Market for Hospitals and Diagnostic Laboratories, by Country, 2021-2031 ($Million)
Table 39. Single Cell Analysis Market Size, for Others, by Region, 2021-2031 ($Million)
Table 40. Single Cell Analysis Market for Others, by Country, 2021-2031 ($Million)
Table 41. Single Cell Analysis Market, by Region, 2021-2031 ($Million)
Table 42. North America Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 43. North America Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 44. North America Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 45. North America Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 46. North America Single Cell Analysis Market, by Country, 2021-2031 ($Million)
Table 47. U.S. Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 48. U.S. Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 49. U.S. Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 50. U.S. Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 51. Canada Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 52. Canada Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 53. Canada Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 54. Canada Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 55. Mexico Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 56. Mexico Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 57. Mexico Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 58. Mexico Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 59. Europe Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 60. Europe Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 61. Europe Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 62. Europe Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 63. Europe Single Cell Analysis Market, by Country, 2021-2031 ($Million)
Table 64. Germany Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 65. Germany Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 66. Germany Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 67. Germany Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 68. France Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 69. France Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 70. France Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 71. France Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 72. U.K. Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 73. U.K. Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 74. U.K. Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 75. U.K. Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 76. Italy Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 77. Italy Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 78. Italy Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 79. Italy Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 80. Spain Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 81. Spain Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 82. Spain Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 83. Spain Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 84. Rest of Europe Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 85. Rest of Europe Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 86. Rest of Europe Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 87. Rest of Europe Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 88. Asia-Pacific Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 89. Asia-Pacific Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 90. Asia-Pacific Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 91. Asia-Pacific Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 92. Asia-Pacific Single Cell Analysis Market, by Country, 2021-2031 ($Million)
Table 93. Japan Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 94. Japan Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 95. Japan Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 96. Japan Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 97. China Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 98. China Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 99. China Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 100. China Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 101. India Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 102. India Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 103. India Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 104. India Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 105. Australia Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 106. Australia Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 107. Australia Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 108. Australia Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 109. South Korea Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 110. South Korea Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 111. South Korea Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 112. South Korea Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 113. Rest of Asia-Pacific Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 114. Rest of Asia-Pacific Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 115. Rest of Asia-Pacific Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 116. Rest of Asia-Pacific Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 117. LAMEA Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 118. LAMEA Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 119. LAMEA Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 120. LAMEA Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 121. LAMEA Single Cell Analysis Market, by Country, 2021-2031 ($Million)
Table 122. Brazil Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 123. Brazil Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 124. Brazil Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 125. Brazil Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 126. Saudi Arabia Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 127. Saudi Arabia Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 128. Saudi Arabia Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 129. Saudi Arabia Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 130. South Africa Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 131. South Africa Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 132. South Africa Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 133. South Africa Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 134. Rest of LAMEA Single Cell Analysis Market, by Product, 2021-2031 ($Million)
Table 135. Rest of LAMEA Single Cell Analysis Market, by Application, 2021-2031 ($Million)
Table 136. Rest of LAMEA Single Cell Analysis Market, by Techniques, 2021-2031 ($Million)
Table 137. Rest of LAMEA Single Cell Analysis Market, by End-user, 2021-2031 ($Million)
Table 138.10X Genomics: Company Snapshot
Table 139.10X Genomics: Operating Segments
Table 140.10X Genomics: Product Portfolio
Table 141.10X Genomics: Net Sales
Table 142.10X Genomics: Key Stratergies
Table 143. Agilent Technologies, Inc.: Company Snapshot
Table 144. Agilent Technologies, Inc.: Operating Segments
Table 145. Agilent Technologies, Inc.: Product Portfolio
Table 146. Agilent Technologies, Inc.: Net Sales
Table 147. Agilent Technologies, Inc.: Key Stratergies
Table 148. Becton, Dickinson and Company: Company Snapshot
Table 149. Becton, Dickinson and Company: Operating Segments
Table 150. Becton, Dickinson and Company: Product Portfolio
Table 151. Becton, Dickinson and Company: Net Sales
Table 152. Becton, Dickinson and Company: Key Stratergies
Table 153. Bio-Rad Laboratories: Company Snapshot
Table 154. Bio-Rad Laboratories: Operating Segments
Table 155. Bio-Rad Laboratories: Product Portfolio
Table 156. Bio-Rad Laboratories: Net Sales
Table 157. Bio-Rad Laboratories: Key Stratergies
Table 158. Danaher Corporation(Cytiva Life Sciences): Company Snapshot
Table 159. Danaher Corporation(Cytiva Life Sciences): Operating Segments
Table 160. Danaher Corporation(Cytiva Life Sciences): Product Portfolio
Table 161. Danaher Corporation(Cytiva Life Sciences): Net Sales
Table 162. Danaher Corporation(Cytiva Life Sciences): Key Stratergies
Table 163. Illumina, Inc.: Company Snapshot
Table 164. Illumina, Inc.: Operating Segments
Table 165. Illumina, Inc.: Product Portfolio
Table 166. Illumina, Inc.: Net Sales
Table 167. Illumina, Inc.: Key Stratergies
Table 168. Berkley Lights Inc: Company Snapshot
Table 169. Berkley Lights Inc: Operating Segments
Table 170. Berkley Lights Inc: Product Portfolio
Table 171. Berkley Lights Inc: Net Sales
Table 172. Berkley Lights Inc: Key Stratergies
Table 173. Bgi Genomics Co. Ltd: Company Snapshot
Table 174. Bgi Genomics Co. Ltd: Operating Segments
Table 175. Bgi Genomics Co. Ltd: Product Portfolio
Table 176. Bgi Genomics Co. Ltd: Net Sales
Table 177. Bgi Genomics Co. Ltd: Key Stratergies
Table 178. Diasorin Group (Luminex Corporation): Company Snapshot
Table 179. Diasorin Group (Luminex Corporation): Operating Segments
Table 180. Diasorin Group (Luminex Corporation): Product Portfolio
Table 181. Diasorin Group (Luminex Corporation): Net Sales
Table 182. Diasorin Group (Luminex Corporation): Key Stratergies
Table 183. Dolomite Bio: Company Snapshot
Table 184. Dolomite Bio: Operating Segments
Table 185. Dolomite Bio: Product Portfolio
Table 186. Dolomite Bio: Net Sales
Table 187. Dolomite Bio: Key Stratergies
Table 188. Merck KGaA: Company Snapshot
Table 189. Merck KGaA: Operating Segments
Table 190. Merck KGaA: Product Portfolio
Table 191. Merck KGaA: Net Sales
Table 192. Merck KGaA: Key Stratergies
Table 193. Oxford Nanaopore Technologies: Company Snapshot
Table 194. Oxford Nanaopore Technologies: Operating Segments
Table 195. Oxford Nanaopore Technologies: Product Portfolio
Table 196. Oxford Nanaopore Technologies: Net Sales
Table 197. Oxford Nanaopore Technologies: Key Stratergies
Table 198. Qiagen N.V: Company Snapshot
Table 199. Qiagen N.V: Operating Segments
Table 200. Qiagen N.V: Product Portfolio
Table 201. Qiagen N.V: Net Sales
Table 202. Qiagen N.V: Key Stratergies
Table 203. Sartorius Ag: Company Snapshot
Table 204. Sartorius Ag: Operating Segments
Table 205. Sartorius Ag: Product Portfolio
Table 206. Sartorius Ag: Net Sales
Table 207. Sartorius Ag: Key Stratergies
Table 208. Standard Biotools (Fluidigm Corporation): Company Snapshot
Table 209. Standard Biotools (Fluidigm Corporation): Operating Segments
Table 210. Standard Biotools (Fluidigm Corporation): Product Portfolio
Table 211. Standard Biotools (Fluidigm Corporation): Net Sales
Table 212. Standard Biotools (Fluidigm Corporation): Key Stratergies
Table 213. Takara Holdings Inc: Company Snapshot
Table 214. Takara Holdings Inc: Operating Segments
Table 215. Takara Holdings Inc: Product Portfolio
Table 216. Takara Holdings Inc: Net Sales
Table 217. Takara Holdings Inc: Key Stratergies
Table 218. Thermo Fisher Scientific, Inc.: Company Snapshot
Table 219. Thermo Fisher Scientific, Inc.: Operating Segments
Table 220. Thermo Fisher Scientific, Inc.: Product Portfolio
Table 221. Thermo Fisher Scientific, Inc.: Net Sales
Table 222. Thermo Fisher Scientific, Inc.: Key Stratergies
List of Figures
Figure 1. Single Cell Analysis Market Segmentation
Figure 2. Single Cell Analysis Market,2021-2031
Figure 3. Single Cell Analysis Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Single Cell Analysis Market:Drivers, Restraints and Opportunities
Figure 12. Single Cell Analysis Market,By Product,2021(%)
Figure 13. Comparative Share Analysis of Consumables Single Cell Analysis Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Instruments Single Cell Analysis Market,2021-2031(%)
Figure 15. Single Cell Analysis Market,By Application,2021(%)
Figure 16. Comparative Share Analysis of Oncology Single Cell Analysis Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Immunology Single Cell Analysis Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Neurology Single Cell Analysis Market,2021-2031(%)
Figure 19. Comparative Share Analysis of Stem Cell Single Cell Analysis Market,2021-2031(%)
Figure 20. Comparative Share Analysis of Non-Invasive Prenatal Diagnosis Single Cell Analysis Market,2021-2031(%)
Figure 21. Comparative Share Analysis of In-Vitro Fertilization (Ivf) Single Cell Analysis Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Others Single Cell Analysis Market,2021-2031(%)
Figure 23. Single Cell Analysis Market,By Techniques,2021(%)
Figure 24. Comparative Share Analysis of Flow Cytometry Single Cell Analysis Market,2021-2031(%)
Figure 25. Comparative Share Analysis of Next Generation Sequencing (Ngs) Single Cell Analysis Market,2021-2031(%)
Figure 26. Comparative Share Analysis of Polymerase Chain Reaction (Pcr) Single Cell Analysis Market,2021-2031(%)
Figure 27. Comparative Share Analysis of Mass Spectrometry Single Cell Analysis Market,2021-2031(%)
Figure 28. Comparative Share Analysis of Others Single Cell Analysis Market,2021-2031(%)
Figure 29. Single Cell Analysis Market,By End-user,2021(%)
Figure 30. Comparative Share Analysis of Academic and Research Laboratories Single Cell Analysis Market,2021-2031(%)
Figure 31. Comparative Share Analysis of Biotechnology and Pharmaceutical Companies Single Cell Analysis Market,2021-2031(%)
Figure 32. Comparative Share Analysis of Hospitals and Diagnostic Laboratories Single Cell Analysis Market,2021-2031(%)
Figure 33. Comparative Share Analysis of Others Single Cell Analysis Market,2021-2031(%)
Figure 34. Single Cell Analysis Market by Region,2021
Figure 35. U.S. Single Cell Analysis Market,2021-2031($Million)
Figure 36. Canada Single Cell Analysis Market,2021-2031($Million)
Figure 37. Mexico Single Cell Analysis Market,2021-2031($Million)
Figure 38. Germany Single Cell Analysis Market,2021-2031($Million)
Figure 39. France Single Cell Analysis Market,2021-2031($Million)
Figure 40. U.K. Single Cell Analysis Market,2021-2031($Million)
Figure 41. Italy Single Cell Analysis Market,2021-2031($Million)
Figure 42. Spain Single Cell Analysis Market,2021-2031($Million)
Figure 43. Rest of Europe Single Cell Analysis Market,2021-2031($Million)
Figure 44. Japan Single Cell Analysis Market,2021-2031($Million)
Figure 45. China Single Cell Analysis Market,2021-2031($Million)
Figure 46. India Single Cell Analysis Market,2021-2031($Million)
Figure 47. Australia Single Cell Analysis Market,2021-2031($Million)
Figure 48. South Korea Single Cell Analysis Market,2021-2031($Million)
Figure 49. Rest of Asia-Pacific Single Cell Analysis Market,2021-2031($Million)
Figure 50. Brazil Single Cell Analysis Market,2021-2031($Million)
Figure 51. Saudi Arabia Single Cell Analysis Market,2021-2031($Million)
Figure 52. South Africa Single Cell Analysis Market,2021-2031($Million)
Figure 53. Rest of LAMEA Single Cell Analysis Market,2021-2031($Million)
Figure 54. Top Winning Strategies, by Year
Figure 55. Top Winning Strategies, by Development
Figure 56. Top Winning Strategies, by Company
Figure 57. Product Mapping of Top 10 Players
Figure 58. Competitive Dashboard
Figure 59. Competitive Heatmap of Top 10 Key Players
Figure 60.10X Genomics.: Net Sales ,($Million)
Figure 61. Agilent Technologies, Inc..: Net Sales ,($Million)
Figure 62. Becton, Dickinson and Company.: Net Sales ,($Million)
Figure 63. Bio-Rad Laboratories.: Net Sales ,($Million)
Figure 64. Danaher Corporation(Cytiva Life Sciences).: Net Sales ,($Million)
Figure 65. Illumina, Inc..: Net Sales ,($Million)
Figure 66. Berkley Lights Inc.: Net Sales ,($Million)
Figure 67. Bgi Genomics Co. Ltd.: Net Sales ,($Million)
Figure 68. Diasorin Group (Luminex Corporation).: Net Sales ,($Million)
Figure 69. Dolomite Bio.: Net Sales ,($Million)
Figure 70. Merck KGaA.: Net Sales ,($Million)
Figure 71. Oxford Nanaopore Technologies.: Net Sales ,($Million)
Figure 72. Qiagen N.V.: Net Sales ,($Million)
Figure 73. Sartorius AG.: Net Sales ,($Million)
Figure 74. Standard Biotools (Fluidigm Corporation).: Net Sales ,($Million)
Figure 75. Takara Holdings Inc.: Net Sales ,($Million)
Figure 76. Thermo Fisher Scientific, Inc..: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Single Cell Analysis Market," the single cell analysis market was valued at $2.64 billion in 2021, and is estimated to reach $13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031.

Single-cell analysis refers to the analysis of a single-cell genome or transcriptome, so as to obtain genomic, transcriptome or other multi-omics information to reveal cell population differences and cellular evolutionary relationships. Traditional analysis methods can only get the average of many cells, unable to analyse a small number of cells and lose cellular heterogeneity information. As compared to traditional analysis technology, single-cell technologies have the advantages of detecting heterogeneity among individual cells, distinguishing a small number of cells, and delineating cell maps. Nowadays, single-cell sequencing technology is increasingly used in various fields including tumours, microbiology, neurology, reproduction, immunity, digestion, and urinary systems.

The key factors that drive the growth of the single cell analysis market size are technological advancement in single cell analysis coupled with increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, rise in focus on personalized medicines and surge in prevalence of cancer are some single cell analysis market trends which further expected to boost the market growth during forecast period. However, higher cost of single cell analysis products is likely to hamper the single cell analysis market growth during the forecast period. Conversely, high growth potential of single cell sequencing is expected to provide numerous opportunities for market growth during the forecast period.

The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By product, the consumable segment dominated the single cell analysis market share in 2021 and is expected to remain dominant during the forecast period, owing to high usability of products and frequent purchase of reagents, increase in prevalence of target diseases and constant need for consumables required for assay.

Depending on application, the oncology segment dominated the market in 2021 and is expected to remain dominant during the forecast period, owing to increase in prevalence of cancer. In addition, single cell analysis proved to be effective for prior diagnostics of cancer cells, thus driving the segment growth. However, neurology segment registered highest CAGR during forecast period, owing to increase in prevalence of neurological disorders.

By technique, the next generation sequencing segment dominated the market in 2021 and is expected to remain dominant during the forecast period, owing to increase in genome mapping programs, rise in applications of next generation sequencing, increase in healthcare expenditure and technological advancements in sequencing platforms.

On the basis of end user, the biotechnology and pharmaceutical industries segment dominated the market in 2021 and is expected to remain dominant during the forecast period, owing to technological advancement such as the use of microfluidics for the development of next generation therapies have increased the adoption of single cell analysis by biotechnology and pharmaceutical companies. Moreover, increase in penetration of genomic technologies in drug development is expected to further drive the market.

Region wise, North America has the highest market share in 2021, and is estimated to register a CAGR of 14.7% during the forecast period owing to the well-established healthcare system, increase in number of geriatric patients, presence of key market players, supportive reimbursement policies in healthcare system. In addition, increase in R&D expenditure and federal funding further boost the market growth. Europe is projected to register the highest CAGR of 21.6% during the forecast period. The increasing per capita income, growing medical tourism industry, and rising public awareness regarding benefits of single cell analysis are the key driving factors that boost the growth of the market in the region.

Key Findings of the Study

  • On the basis of product, the consumables segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • On the basis of application, the oncology segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • On the basis of technique, the next generation sequencing segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • Depending on end user, biotechnology and pharmaceutical companies' segment is projected to grow at a CAGR of 17.6% during the forecast period.
  • Region-wise, North America garnered the largest revenue share in cell analysis industry in 2021. However, Europe is anticipated to grow at the highest CAGR 21.6% during the forecast period.

Companies Mentioned

  • 10X Genomics
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Danaher Corporation(Cytiva Life Sciences)
  • Illumina, Inc.
  • Berkley Lights Inc
  • Bgi Genomics Co. Ltd
  • Diasorin Group (Luminex Corporation)
  • Dolomite Bio
  • Merck Kgaa
  • Oxford Nanaopore Technologies
  • Qiagen N.V
  • Sartorius AG
  • Standard Biotools (Fluidigm Corporation)
  • Takara Holdings Inc
  • Thermo Fisher Scientific, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information